Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL270812 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL7616706 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL28162 | 1.00 | — | — | |
| SCHEMBL51303 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL21048444 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL23668483 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL5675255 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL15158032 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL20943436 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL2734408 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210284786-A1 | A FLEXIBLE FOAM FORMULATION AND METHOD OF PRODUCING THE SAME | BASF SE (DE) | 2021-09-16 | — | — | US | disclosed |
| CN-111233926-B | Thiamine compound, preparation method and pharmaceutical composition thereof | 上海日馨生物科技有限公司 | 2021-04-16 | — | — | CN | disclosed |
| CN-111233925-B | Thiamine compound, preparation method and pharmaceutical composition thereof | 上海日馨生物科技有限公司 | 2021-03-26 | — | — | CN | disclosed |
| US-10800895-B2 | Polymer slides having hydrophobic small molecules | STRATEC CONSUMABLES GmbH (AT) | 2020-10-13 | — | — | US | disclosed |
| CN-111233926-A | Thiamine compound, preparation method and pharmaceutical composition thereof | 上海日馨生物科技有限公司 | 2020-06-05 | — | — | CN | disclosed |
| CN-111233925-A | Thiamine compound, preparation method and pharmaceutical composition thereof | 上海日馨生物科技有限公司 | 2020-06-05 | — | — | CN | disclosed |
| US-10611890-B2 | Method of producing a polymer part and polymer part | STRATEC CONSUMABLES GmbH (AT) | 2020-04-07 | — | — | US | disclosed |
| EP-2792471-B1 | Polymer parts | STRATEC CONSUMABLES GmbH (AT) | 2018-01-31 | — | — | EP | disclosed |
| US-9669049-B2 | Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders | TOCAGEN INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-20170029587-A1 | METHOD OF PRODUCING A POLYMER PART AND POLYMER PART | STRATEC CONSUMABLES GmbH (AT) | 2017-02-02 | — | — | US | disclosed |
| EP-2792471-A1 | Polymer parts | Sony DADC Austria AG (AT) | 2014-10-22 | — | — | EP | disclosed |
| US-20140309375-A1 | METHOD OF PRODUCING A POLYMER PART AND POLYMER PART | SONY DADC AUSTRIA AG (AT) | 2014-10-16 | — | — | US | disclosed |
| US-7906147-B2 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | NANOPROBES, INC. (US) | 2011-03-15 | — | — | US | disclosed |
| CN-1495293-B | Surfactant enhanced protection method for preventing micromechanical component from electrically ageing | ALTERA CORP | 2010-10-27 | — | — | CN | disclosed |
| US-20080089836-A1 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | NANOPROBES, INC. (US) | 2008-04-17 | — | — | US | disclosed |
| CN-1495293-A | Surfactant enhanced protection method for preventing micromechanical component from electrically ageing | PTS | 2004-05-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080089836-A1 | superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography | TFRC, FABP1, SCARB1 | TSHR 1345/4885THRB 962/4885DNM1 268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.